Abstract
Genome-wide association studies have identified several risk associations for ovarian carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC cases and 21,693 controls with imputation identified 3 new risk associations: rs752590 at 2q13 (P = 3.3 × 10-8), rs711830 at 2q31.1 (P = 7.5 × 10-12) and rs688187 at 19q13.2 (P = 6.8 × 10-13). We identified significant expression quantitative trait locus (eQTL) associations for HOXD9 at 2q31.1 in ovarian (P = 4.95 × 10-4, false discovery rate (FDR) = 0.003) and colorectal (P = 0.01, FDR = 0.09) tumors and for PAX8 at 2q13 in colorectal tumors (P = 0.03, FDR = 0.09). Chromosome conformation capture analysis identified interactions between the HOXD9 promoter and risk-associated SNPs at 2q31.1. Overexpressing HOXD9 in MOC cells augmented the neoplastic phenotype. These findings provide the first evidence for MOC susceptibility variants and insights into the underlying biology of the disease.
Original language | English (US) |
---|---|
Pages (from-to) | 888-897 |
Number of pages | 10 |
Journal | Nature Genetics |
Volume | 47 |
Issue number | 8 |
DOIs | |
State | Published - Aug 30 2015 |
ASJC Scopus subject areas
- Genetics
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Genome-wide significant risk associations for mucinous ovarian carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Nature Genetics, Vol. 47, No. 8, 30.08.2015, p. 888-897.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Genome-wide significant risk associations for mucinous ovarian carcinoma
AU - Kelemen, Linda E.
AU - Lawrenson, Kate
AU - Tyrer, Jonathan
AU - Li, Qiyuan
AU - Lee, Janet M.
AU - Seo, Ji Heui
AU - Phelan, Catherine M.
AU - Beesley, Jonathan
AU - Chen, Xiaoqing
AU - Spindler, Tassja J.
AU - Aben, Katja K.H.
AU - Anton-Culver, Hoda
AU - Antonenkova, Natalia
AU - Baker, Helen
AU - Bandera, Elisa V.
AU - Bean, Yukie
AU - Beckmann, Matthias W.
AU - Bisogna, Maria
AU - Bjorge, Line
AU - Bogdanova, Natalia
AU - Brinton, Louise A.
AU - Brooks-Wilson, Angela
AU - Bruinsma, Fiona
AU - Butzow, Ralf
AU - Campbell, Ian G.
AU - Carty, Karen
AU - Chang-Claude, Jenny
AU - Chen, Y. Ann
AU - Chen, Zhihua
AU - Cook, Linda S.
AU - Cramer, Daniel W.
AU - Cunningham, Julie M.
AU - Cybulski, Cezary
AU - Dansonka-Mieszkowska, Agnieszka
AU - Dennis, Joe
AU - Dicks, Ed
AU - Doherty, Jennifer A.
AU - Dörk, Thilo
AU - Bois, Andreas Du
AU - Dürst, Matthias
AU - Eccles, Diana
AU - Easton, Douglas T.
AU - Edwards, Robert P.
AU - Eilber, Ursula
AU - Ekici, Arif B.
AU - Engelholm, Svend Aage
AU - Fasching, Peter A.
AU - Fridley, Brooke L.
AU - Gao, Yu Tang
AU - Gentry-Maharaj, Aleksandra
AU - Giles, Graham G.
AU - Glasspool, Rosalind
AU - Goode, Ellen L.
AU - Goodman, Marc T.
AU - Grownwald, Jacek
AU - Harrington, Patricia
AU - Harter, Philipp
AU - Hasmad, Hanis Nazihah
AU - Hein, Alexander
AU - Heitz, Florian
AU - Hildebrandt, Michelle A.T.
AU - Hillemanns, Peter
AU - Hogdall, Estrid
AU - Hogdall, Claus
AU - Hosono, Satoyo
AU - Iversen, Edwin S.
AU - Jakubowska, Anna
AU - Jensen, Allan
AU - Ji, Bu Tian
AU - Karlan, Beth Y.
AU - Kellar, Melissa
AU - Kelley, Joseph L.
AU - Kiemeney, Lambertus A.
AU - Krakstad, Camilla
AU - Kjaer, Susanne K.
AU - Kupryjanczyk, Jolanta
AU - Lambrechts, Diether
AU - Lambrechts, Sandrina
AU - Le, Nhu D.
AU - Lee, Alice W.
AU - Lele, Shashi
AU - Leminen, Arto
AU - Lester, Jenny
AU - Levine, Douglas A.
AU - Liang, Dong
AU - Lissowska, Jolanta
AU - Lu, Karen
AU - Lubinski, Jan
AU - Lundvall, Lene
AU - Massuger, Leon F.A.G.
AU - Matsuo, Keitaro
AU - McGuire, Valerie
AU - McLaughlin, John R.
AU - McNeish, Iain
AU - Menon, Usha
AU - Modugno, Francesmary
AU - Moes-Sosnowska, Joanna
AU - Moysich, Kirsten B.
AU - Narod, Steven A.
AU - Nedergaard, Lotte
AU - Ness, Roberta B.
AU - Nevanlinna, Heli
AU - Adenan, Noor Azmi Mat
AU - Odunsi, Kunle
AU - Olson, Sara H.
AU - Orlow, Irene
AU - Orsulic, Sandra
AU - Weber, Rachel Palmieri
AU - Paul, James
AU - Pearce, Celeste Leigh
AU - Pejovic, Tanja
AU - Pelttari, Liisa M.
AU - Permuth-Wey, Jennifer
AU - Pike, Malcolm C.
AU - Poole, Elizabeth M.
AU - Ramus, Susan J.
AU - Risch, Harvey A.
AU - Rosen, Barry
AU - Rossing, Mary Anne
AU - Rothstein, Joseph H.
AU - Rudolph, Anja
AU - Runnebaum, Ingo B.
AU - Rzepecka, Iwona K.
AU - Salvesen, Helga B.
AU - Schildkraut, Joellen M.
AU - Schwaab, Ira
AU - Shu, Xiao Ou
AU - Shvetsov, Yurii B.
AU - Siddiqui, Nadeem
AU - Sieh, Weiva
AU - Song, Honglin
AU - Southey, Melissa C.
AU - Sucheston, Lara
AU - Tangen, Ingvild L.
AU - Teo, Soo Hwang
AU - Terry, Kathryn L.
AU - Thompson, Pamela J.
AU - Tworoger, Shelley S.
AU - Van Altena, Anne M.
AU - Nieuwenhuysen, Els Van
AU - Vergote, Ignace
AU - Vierkant, Robert A.
AU - Shan, Wang Gohrke
AU - Walsh, Christine
AU - Wentzensen, Nicolas
AU - Whittemore, Alice S.
AU - Wicklund, Kristine G.
AU - Wilkens, Lynne R.
AU - Sawicki, Wlodzimierz
AU - Woo, Yin Ling
AU - Wu, Xifeng
AU - Wu, Anna H.
AU - Yang, Hannah
AU - Zheng, Wei
AU - Ziogas, Argyrios
AU - Sellers, Thomas A.
AU - Freedman, Matthew L.
AU - Chenevix-Trench, Georgia
AU - Pharoah, Paul D.P.
AU - Gayther, Simon A.
AU - Berchuck, Andrew
N1 - Funding Information: We thank all the individuals who took part in this study and all the researchers, clinicians, and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note). The COGS project is funded through a European Commission’s Seventh Framework Programme grant (agreement 223175–HEALTH-F2-2009-223175). The Ovarian Cancer Association Consortium (OCAC) is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were supported in part by Genetic Associations and Mechanisms in Oncology (GAME-ON) and a National Cancer Institute Cancer Post-GWAS Initiative (U19-CA148112). Details of the funding of individual investigators and studies are provided in the Supplementary Note. This study made use of data generated by the Wellcome Trust Case Control Consortium; funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the consortium website (see URLs). The results published here are based in part on data generated by The Cancer Genome Atlas (TCGA) Pilot Project established by the National Cancer Institute and National Human Genome Research Institute; information about TCGA and the investigators and institutions who constitute the TCGA research network can be found on the project website (see URLs). Publisher Copyright: © 2015 Nature America, Inc. All rights reserved.
PY - 2015/8/30
Y1 - 2015/8/30
N2 - Genome-wide association studies have identified several risk associations for ovarian carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC cases and 21,693 controls with imputation identified 3 new risk associations: rs752590 at 2q13 (P = 3.3 × 10-8), rs711830 at 2q31.1 (P = 7.5 × 10-12) and rs688187 at 19q13.2 (P = 6.8 × 10-13). We identified significant expression quantitative trait locus (eQTL) associations for HOXD9 at 2q31.1 in ovarian (P = 4.95 × 10-4, false discovery rate (FDR) = 0.003) and colorectal (P = 0.01, FDR = 0.09) tumors and for PAX8 at 2q13 in colorectal tumors (P = 0.03, FDR = 0.09). Chromosome conformation capture analysis identified interactions between the HOXD9 promoter and risk-associated SNPs at 2q31.1. Overexpressing HOXD9 in MOC cells augmented the neoplastic phenotype. These findings provide the first evidence for MOC susceptibility variants and insights into the underlying biology of the disease.
AB - Genome-wide association studies have identified several risk associations for ovarian carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC cases and 21,693 controls with imputation identified 3 new risk associations: rs752590 at 2q13 (P = 3.3 × 10-8), rs711830 at 2q31.1 (P = 7.5 × 10-12) and rs688187 at 19q13.2 (P = 6.8 × 10-13). We identified significant expression quantitative trait locus (eQTL) associations for HOXD9 at 2q31.1 in ovarian (P = 4.95 × 10-4, false discovery rate (FDR) = 0.003) and colorectal (P = 0.01, FDR = 0.09) tumors and for PAX8 at 2q13 in colorectal tumors (P = 0.03, FDR = 0.09). Chromosome conformation capture analysis identified interactions between the HOXD9 promoter and risk-associated SNPs at 2q31.1. Overexpressing HOXD9 in MOC cells augmented the neoplastic phenotype. These findings provide the first evidence for MOC susceptibility variants and insights into the underlying biology of the disease.
UR - http://www.scopus.com/inward/record.url?scp=84938292950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938292950&partnerID=8YFLogxK
U2 - 10.1038/ng.3336
DO - 10.1038/ng.3336
M3 - Article
C2 - 26075790
AN - SCOPUS:84938292950
SN - 1061-4036
VL - 47
SP - 888
EP - 897
JO - Nature Genetics
JF - Nature Genetics
IS - 8
ER -